Health StatusNCT07249099
Cohort of Cord Blood Bank
An observational study of Health Status and Childhood Diseases, run by Institute of Hematology & Blood Diseases Hospital, China at 1 site in China.
Trial summary
The objective of this observational study was to establish a cohort of umbilical cord blood stored in Tianjin Cord Blood Bank. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Health Status, Childhood Diseases
- How many people
- 2,000 participants
- Where
- 1 siteChina
- Study dates
- 25 Mar 2025to 31 Dec 2030
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Child, Adult, Older adult
Study population: People stored umbilical cord blood in Tianjin Cord Blood Bank
Who may be able to join
- Voluntarily participated in this study and provided signed informed consent forms.
- People stored umbilical cord blood in Tianjin Cord Blood Bank.
- The information registered at the time of storage is complete and the contact details are genuine and available.
Who cannot join
- Refusing to answer the researcher's phone or refusing to accept the investigation.
- People who are unable or unsuitable to participate in the study for various other reasons .
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
China1 site
Institute of Hematology & Blood Diseases Hospital
Tianjin, Tianjin Municipality, 300000
About this study
Official title: Cohort of Cord Blood Bank (CCBN)
The objective of this observational study was to establish a cohort of umbilical cord blood stored in Tianjin Cord Blood Bank.
Read the detailed description
This is an observational study. It is planned to observe the incidence and death of common chronic non-communicable diseases, rare diseases and key diseases through follow-up of environmental exposure in the early life of the study population and investigation of adverse lifestyle of mothers during pregnancy, and explore the influence of factors including genetics, environment and lifestyle on the occurrence, development and prognosis of the diseases concerned.
- Conditions
- Health Status, Childhood Diseases
- Keywords
- umbilical cord blood, Health status of people stored umbilical cord blood
What is being measured
The primary outcome is the main question the study is designed to answer.
Health status
The health status of people stored umbilical cord blood
Measured: The diseases status of participants will be assessed at baseline and at follow-up visits every 3 to 5 years, up to 10 years. The events include the occurrence of childhood diseases at baseline, as well as disease progression or death during follow-up.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Nov 2025
- Study start25 Mar 2025
- Primary completion31 Dec 2026 (estimated)
- Study completion31 Dec 2030 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Health StatusStudies of the same condition, open and under way.
- More trials run by Institute of Hematology & Blood Diseases Hospital, ChinaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Other
- Enrolment
- 2,000 participants (estimated)
Sponsor and investigators
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07249099
- Sponsor's protocol ID
- QTJC2025029
- Status last verified
- Mar 2025
- First submitted
- 1 Aug 2025
- Last updated
- 25 Nov 2025
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 25 Nov 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Cohort of Cord Blood Bank (CCBN)
- ClinicalTrials.gov ID
- NCT07249099
- Acronym / sponsor ID
- QTJC2025029
- Conditions
- Health Status, Childhood Diseases
- Keywords
- umbilical cord blood, Health status of people stored umbilical cord blood
- Study type
- Observational
- Recruitment status
- Enrolling by invitation
- Enrolment
- 2,000 participants (estimated)
- Lead sponsor
- Institute of Hematology & Blood Diseases Hospital, ChinaUniversity, hospital or other
- Study start
- 25 Mar 2025 (actual)
- Primary completion
- 31 Dec 2026 (estimated)
- Study completion
- 31 Dec 2030 (estimated)
- First posted
- 25 Nov 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The objective of this observational study was to establish a cohort of umbilical cord blood stored in Tianjin Cord Blood Bank.
Detailed description
This is an observational study. It is planned to observe the incidence and death of common chronic non-communicable diseases, rare diseases and key diseases through follow-up of environmental exposure in the early life of the study population and investigation of adverse lifestyle of mothers during pregnancy, and explore the influence of factors including genetics, environment and lifestyle on the occurrence, development and prognosis of the diseases concerned.
Study design
- Observational model
- Cohort
- Time perspective
- Other
Who may qualify
- Sex
- All
- Age groups
- Child, Adult, Older adult
- Study population
- People stored umbilical cord blood in Tianjin Cord Blood Bank
Key inclusion criteria (3 listed)
- Voluntarily participated in this study and provided signed informed consent forms.
- People stored umbilical cord blood in Tianjin Cord Blood Bank.
- The information registered at the time of storage is complete and the contact details are genuine and available.
Key exclusion criteria (2 listed)
- Refusing to answer the researcher's phone or refusing to accept the investigation.
- People who are unable or unsuitable to participate in the study for various other reasons .
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Health status
Time frame: The diseases status of participants will be assessed at baseline and at follow-up visits every 3 to 5 years, up to 10 years. The events include the occurrence of childhood diseases at baseline, as well as disease progression or death during follow-up.
The health status of people stored umbilical cord blood
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Nov 2025.
Related trials for Health Status
Active, not recruiting
AI-Supported Mobile High-Impact and Strengthening Exercise Program in Postmenopausal Women With Low Bone Density
Osteopenia
Recruiting
CBCT vs OPT on the Oral Health Status at 12 Months of Patients Hospitalized for Infective Endocarditis.
Infective Endocarditis
Active, not recruitingPhase 2
TCM Formula vs. HMB in Pre-Frail Elders: Muscle Strength and Bone Status
Pre-Frailty, Sarcopenia
Recruiting
Evaluation of the Impact of the EDIT-B® Blood Test on the Health Status of Patients Presenting a Major Depressive Episode. Clinical Utility and Medico-Economic Aspects
Bipolar Disorder, Major Depressive Disorder
Recruiting
Applying CSNAT in HBPC as an Approach to Elder Mistreatment Risk Reduction
Caregiver Stress, Caregiver Health Related QOL
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Health Status and Childhood Diseases, run by Institute of Hematology & Blood Diseases Hospital, China at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 25 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Health status (time frame: The diseases status of participants will be assessed at baseline and at follow-up visits every 3 to 5 years, up to 10 years. The events include the occurrence of childhood diseases at baseline, as well as disease progression or death during follow-up.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Nov 2025.